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ABSTRACT: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the 
premature death of motor neurons. In approximately 10% of the cases the disease is inherited as 
autosomal dominant trait (FALS). It has been found that mutations in the Cu/Zn superoxide dismutase 
gene (SODl) are responsible for approximately 15% of FALS kindreds. We screened affected 
individuals from 70 unrelated FALS kindreds and identified 10 mutations, 6 of which are novel. 
Surprisingly, we have found a mutation in exon 3, which includes most of the active site loop and Zn2+ 
binding sites, a region where no previous SODl mutations have been found. Our data increase the 
number of different SODl mutations causing FALS to 55, a significant fraction of the 154 amino acids 
of this relatively small protein. 
RESUME: Identification de six nouvelles mutations dans le gene SODl de patients atteints de la 
Sclerose Laterale Amyotrophique. La Sclerose Laterale Amyotrophique (SLA) est une maladie 
neurodegenerative caracterisee par la mort prematuree des motoneurones. Dans 10% des cas, la SLA 
est herediataire et caracterisee par une transmission autosomique dominante (SLAF). II a ete prouve 
que des mutations dans le gene codant pour la Cu/Zn superoxyde dismutase (SODl) sont responsables 
de 15% des cas de SLAF. L'analyse des regions condantes du gene SODl de 70 patients non-
apparentes atteints de SLAF nous a permis de decouvrir 10 mutations dont six sont nouvelles. Fait 
inatendu, nous avons trouve la premiere mutation dans l'exon 3 qui code pour la majeure partie du site 
actif et des sites de fixation du Zn2+. De plus, nous avons identife une deuxieme mutation recessive. 
Cette etude porte le nombre de mutations SODl differentes a 55 impliquant 37 codons, une fraction 
significative de cette proteine relativement petite constitute de 154 acides amines. 
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Amyotrophic lateral sclerosis (ALS) is a fatal neurological 
disorder characterized by progressive degeneration of large motor 
neurons in the motor cortex, brainstem and spinal cord. The mean 
age at onset of the disease is 45 years with a mean survival of 3 
years.1-2 ALS occurs in two clinically indistinguishable forms, 
sporadic (SALS; 90%) and familial (FALS; 10%). FALS is 
usually inherited as autosomal dominant trait3 though a few 
kindreds show autosomal recessive inheritance.4'5 
Approximately 15% of all dominant FALS are caused by a 
defect in the cytosolic Cu/Zn superoxide dismutase gene (SODl) 
localized to human chromosome 21q22.1.6,7 To date forty-five 
different missense mutations affecting 34 codons, one nonsense 
mutation, one deletion mutation causing a frameshift and two 
intronic mutation in intron 4 have been described in the SODl 
gene.8 All the SODl mutations are dominant except for the 
Asp90Ala mutation which is thought to be recessive.5-9 In order to 
study the effect of these mutations and to gain insight into the 
mechanisms leading to motor neuron degeneration animal models 
of FALS have been generated using mutant SODl transgenes.1012 
We have screened genomic DNA from 70 unrelated patients 
for mutations in the SODl gene by PCR-SSCP. Here, we report 
six new and unpublished SODl gene mutations found in six 
unrelated patients. 
PATIENTS AND METHODS 
Patients 
Blood was collected from 70 unrelated patients with FALS. 
These FALS kindreds were of Canadian and French origins. The El 
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Escorial diagnostic criteria were used.13 Genomic DNA was 
prepared from blood using standard procedures. 
Primer design, SSCP analysis and direct sequencing 
To improve the PCR amplification of SODl gene exons for 
SSCP screening, we designed new intronic primers for exons 1 to 3 
(Table 1). PCR amplification of exons 4 and 5 was performed using 
primers as previously described.14 
The 50 ul amplification reaction contained 100 ng of genomic 
DNA, IX PCR buffer (Promega), 100 ng of each primer, 50 uM of 
dCTP, 50 uM of dGTP, 50 uM of dTTP, 25 uM of dATP, 12.5 uM of 
(a-35S)-dATP (1,000 mCi/mmol, Amersham) and 1.5 units of Tag 
polymerase (Promega). All SODl gene exons were amplified using 
thirty cycles of amplification: 30 s at 94°C, 30 s at 59°C (62°C for 
exon 2) and 45 s at 72° C followed by a 5-min extension at 72°C. 
The single-strand conformational polymorphism (SSCP) 
analysis15 was performed as described by Michaud et al.16 except for 
using an acrylamide concentration of 8% in the gels. In order to 
maximize the mutation detection, we also used the 0.5X Hydrolink 
MDE gel supplemented with or without 5% glycerol. 
Electrophoretic migration at 6V and autoradiology were performed 
for 16 and 18 hours, respectively. Any difference in migration 
between patient and control samples was noted as positive. To 
confirm the SSCP results, symmetric direct sequencing method1718 
using modified T7 polymerase (sequenase, Amersham) was used as 
described by Brody et al.19 All exons were sequenced at least once 
on each strand. 
RESULTS 
In our hands the new oligonucleotide primers designed to 
amplify exons 1-3 (Table 1) gave clearer and more intense bands on 
SSCP than those described in reference 14. Genomic DNA from 70 
unrelated FALS affected patients and from 26 normal controls were 
screened for mutations in SODl gene in all 5 exons using primers 
from the flanking intron sequences. PCR-SSCP analysis of all 
DNA samples showed variant bands in 10 unrelated families 
(14.3%). We had previously screened 300 controls for mutations in 
these exons; none were found. 
Direct sequencing of PCR-amplified DNA from the 10 FALS 
individuals with SSCP variants confirmed the presence of 
mutations in all cases. We identified 6 new mutations of which 5 
were missense nucleotide substitutions and one 3 bp deletion in 
intron 4 (Table 2). Two other known mutations were found in four 
patients (Asp90Ala and Ilel 13Thr).5-20 All affected patients with the 
SODl mutations are heterozygotes except for Leu84Phe and 
Asp90Ala amino acid substitutions where patients were 
homozygous. The 3 bp (CTT) deletion detected in intron 4 is 30 bp 
downstream of exon-intron splice junction. 
DISCUSSION 
All 5 exons of the SODl gene from 70 unrelated FALS affected 
patients were screened for mutations using SSCP. Using our SSCP 
protocol, which involves testing of DNA fragments smaller than 
300 bp using many different gel conditions, we expect to have 
Table 1: Amplified DNA length, annealing temperature and oligonucleotide primer sequences for PCR amplification of Human SODl gene exons. 
Exon 
DNA 
length 
(bp) 
Annealing 
temperature 
(°C) 
Oligonucleotide primers 
Forward Reverse 
1 
2 
3 
4 
5 
209 
260 
342 
242 
249 
55 
62 
59 
59 
59 
5' CGTCTGGGGTTTCCGT 3' 
5' GTCTGGCTGCTTTTTACTTCA 3' 
5' CTTGTTTCTGTTCCCTTCT 3' 
5' CATCAGCCCTAATCCATCTGA 3' 
5' GTAGTGATTACTTGACAGCCCA 3' 
5' CGTCCATGCAAAGGGT 3' 
5' GGGGCTACTCTACTGTTTACT 3' 
5' GGGAAACACGGAATTATCT 3' 
5' TGGATCTTAGAATTCGCGAC 3' 
5' AACAGATGAGTTAAGGGGCCT 3' 
Table 2: Novel SODl mutations in familial amyotrophic lateral sclerosis. 
Codon 
changes 
Restriction site 
changes 
Amino acid 
substitution 
Structural location" Mammalian 
amino acid identityb 
Exon 2 
Exon 3 
Exon 4 
GAG6 GGG 
CTG6 CGG 
GAG6 AAG 
CTA6 CGA 
-TaqI 
-BspH I 
-Nla III 
+Taq I, 
+MboI 
+Sau3A I 
Glu21 Gly 
Leu 38 Arg 
Glu 49 Lys 
Leu 67 Arg 
3 strand 
Greek key 
Cu2+ binding site 
or dimer contact 
Active site loop 
8/8 
8/8 
3/8 
6/8 
TTG6TTC Leu 84 Phe Zinc binding site 8/8 
Intron 4 AAAACTTCTTCTAA6 AAAACTTCTAA 
• Structural location is predicted as reported by H.X. Deng et al.21 
b
 Frequency in which amino acid is conserved in 8 different mammals. 
+
 and - indicate a gain and loss of the corresponding restriction site. 
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consensus 
human 
rabbit 
horse 
pig 
cow 
sheep 
mouse 
rat 
chicken 
swordfish 
shark 
fruit fly 
A T - K A V C V L K G D G P 
A T - K A V C V L K G D G P 
A T - K A V C V L K G D G P 
A L - K A V C V L K G D G F 
A T - K A V C V L K G D G P 
A T - K A V C V L K G D G P 
A T - K A V C V L K G D G P 
A K - K A V C V L K G D G P 
A N - K A V C V L K O D O P 
A T L K A V C V N K G D G P 
V Q G T X H F E Q K A S G - P V V V K G 
V Q 0 I I N F 
V B A T X H F 
V H G V I H F 
V Q 0 I I R F 
V 0 0 T X H F 
V Q 0 T I R F 
V Q G T X H F 
v g g v i H P 
V B G V X B F 
- V L K A V C V L R G A O E T T O T V y r 
K A V C V L K G T G B 
- V V K A V C V I H O D - -
D. Simulans - V V K A V C V I N G D - -
xenopus 
haemonchus 
consensus 
human 
rabbit 
horse 
pig 
cow 
sheep 
mouse 
rat 
chicken 
swordfish 
shark 
fruit fly 
V T 0 T V L F 
V K 0 T V H F 
A K 0 T V F F 
- - V R A V C V L A O S O D V K G V V H F 
S N - R A V A V L R O D P G 
r G D N T N G C T S A G P H 
P G D N T A G C T S A G P H 
P O D N R O O C T S A G P H 
F O D N T Q G C T T A G A H 
F G D M T O G C T S A G P H 
F G D N T Q G C T S A G P H 
F G D N T Q G C T S A O P H 
Y G D M T Q G C T S A O P H 
Y G D N T Q G C T T A G P H 
F G D N T N G C T S A G A H 
P G D N T N G C X S A G P K 
F G D N T N G C I S A G P H 
F G D N T N G C T S A O P H 
D. Simulans F O D N T N O C M S S G P K 
xenopus 
haemonchus 
consensus 
human 
rabbit 
horse 
pig 
cow 
sheep 
mouse 
rat 
chicken 
swordfish 
shark 
fruit fly 
F O D N T N G C M S A G P H 
Y G D S T N G C T S A G P H 
E D S V I S L 5 G B H S I I 
E D 8 V I 8 L S G D H C I I 
B D S V I S L S G D N S V X 
K D S V X 8 L S G K K S X X 
E D S L X S L S G A N S X X 
V D P L I S L S G E Y S I I 
V D P L X S L S G E Y S I I 
E D R V I S L S G B H S I I 
E D R V X S L S G E H S I X 
E D S V X S L T G P H C X X 
T D K - I S L T O P Y S I I 
K D R Q L H L S Q E R S I I 
V T O T V W F 
E 
E 
E 
B 
B 
B 
E 
E 
Q 
E 
E 
B 
E 
E 
S 
Q K B S H C P V K V W G 
Q K G T O - P V V V K G 
O Q Q E G G P V V L K G 
O K A N G - P V V V R G 
A K - - O D T V V V T O 
A K - - G D X V V V T G 
Q K A S O B P V V L S G 
Q K A S O B P V V V S G 
Q 0 G 8 O - P V K V T O 
Q E O H A N A V G K O I 
Q A A D G - P V T L X G 
Q Q D A K 8 P V L V T G 
Q E S S G T P V K V S G 
Q Q D B Q - A V S V E O 
Q D K B S D P C V X K G 
F N P L S K K H G G P K D B E R H V O D 
F N P 
F N P 
rut 
F N P 
F N P 
F H P 
F N P 
F N P 
F N P 
F N P 
Y N P 
F N P 
F N P 
F N P 
F N P 
T 
L 
L 
L 
L 
L 
R 
R 
E 
A 
F 
Y 
Y 
E 
£. 
S R K H G O P K D B B R H V G D 
S K K R G G P K D B B R H V G D 
S K K H G G P K D E B R H V a D 
S K K H G G P Q D B B R K V G D 
S K K H G G P X D B E R K V O D 
S K K H G G P K D B B R R V O D 
S K K H G O P A D E E R H V O D 
S K K H O G P A D E B R R V G D 
G K Q H G G P K D A D R H V G D 
S K K H A G P K D E D R H V G E 
S K N K O a P D D E E R M V G D 
C N S H G A P S D L N R H L G D 
G K E H O A P V D 8 N R H L G D 
N K N K O A P G D T D R B V O D 
S I T G L T E G L H G F H V K E 
S I K G 
R X T G 
F X E 0 
R I T G 
S I T G 
8 I T G 
0 I T G 
0 I T G 
K I T G 
I L K G 
8 I T 0 
E V N G 
B V C G 
X I E 0 
B I K 0 
LJT E 0 L H G F H V H 
L 
L 
L 
L 
L 
L 
T E G L H E F H V H 
T K G D H G F H V H 
V E G K H G F K V H 
T B G D H G F H V H 
T E G D H G P H V H 
T E O Q H G F H V H 
L T E O E H G F H V H 
L S D G D H G F H V H 
L 
L 
L 
L 
L 
L 
T P O B H G F H V H 
T P G K H G F H V H 
A K G L H G F H V H 
A K G L H G P H V H 
T D G L H G F H I H 
"E 
Q 
E 
E 
Q 
Q 
Q 
Q 
E 
C 
A 
E 
E 
V 
T P C L H G P H V U12 
L G N V T A G K D G V A D V S X 
r L 
L 
L 
L 
L 
L 
L 
I 
L 
I 
I 
I 
I 
N K T K G O P K D D V R H V G D{j, 
O R T M V V H E K A D D L G K O G 
O R T L V V K B K A D D L G K G G - - -
G R T L V V H E K B D D L O K O O 
G R T M V V H E K Q D D L O K O G 
G R T M V V H E K P D D L O K O G - - -
O R T M V V H E K P D D L O R G G - - -
G R T M V V H E K P D D L G R O G - - -
G R T M V V H E K Q D D L G K G G - - -
G R T M V V R E K O D D L G K O G - - -
G R T M V V R A K S D D L O R O G 
G R T M V X R B K A D D L G R O G 
G R T L V V H E K B D D L G K C G - - -
S D K L I T L F G B N S X V G R T X V V K A D P D D L G X O O - - -
D. Simulans T D S K I T L F O A D S I I 
xenopus 
haemonchus 
consensus 
human 
rabbit 
horse 
pig 
cow 
sheep 
mouse 
rat 
chicken 
swordfish 
shark 
fruit fly 
D. Simulans 
xenopus 
haemonchus 
T D S L X S L K O P N S X X 
K D H L V K X H O B R T V V 
O V I G I A - K - 152 
G V I G X A - P 153 
G V I G X S - P 152 
G V X G X A - 0 153 
G V X G X A - 0 152 
G V I G X A - K 151 
G V X O X A - P 151 
G V X O X A - Q 153 
G V X G I A - Q 153 
G V X G I A - K C 153 
G V I G T E 151 
G V X G I A - K D 151 
G V X G I C - K X 152 
O V I G I A - K V 152 
G V X G Y S - P 150 
G V I A T A A P Q 158 
G R T V V V H A D A D D L G Q G G - - -
G R T A V V H E X A D D L G K O G - - -
G R S L V V R A G T D D L G X O V O E K 
O N V T A D K D G V A D V S I 
Q N V T A G S N G V A D V L I 
O N V T A D E N G K A D V D K 
O N V T A G A D G V A N V S I 
O N V T A D K N O V A I V D I 
O N V K A D K N G V A I V D I 
G N V T A G K D G V A N V S I 
G N V A A G K D G V A N V S I 
G N V T A - K G G V A E V E I 
G N V T A D A N G V A K I D I 
G N V B A N G N G V A E F E I 
O N I E A S G D G A T K V E I 
G N I B A T G D C P T K V N I 
O H V T A - B G G V A O F K I 
G N V B A G A D G V A H P E I 
N E E S T K T G N A G S R L A C 
N E E S T K T G N A G S R L A C 
N D E S T K T G N A G S R L A C 
K E B S T K T G H A G S R L A C 
N E E S T K T G N A G S R L A C 
N E E S T K T G N A G S R L A C 
K E B S T K T G N A G G R L A C 
N E E S T K T G N A G S R L A C 
N E E S T K T G N A G S R L A C 
D N E S K L T G N A G P R L A C 
N E E S L K T O N A G S R L A C 
D E B 8 L R T G N A G S R L A C 
H E L S K T T G N A G A R L G C 
H E L S K S T G N A G A R I G C 
N D E S L K T G N A G G R L A C 
K E B 8 L K T O N R G A R V A C 
48 
49 
48 
49 
48 
47 
47 
49 
49 
49 
49 
46 
47 
47 
47 
49 
98 
99 
98 
99 
98 
97 
97 
99 
99 
98 
99 
96 
97 
97 
96 
99 
145 
146 
145 
146 
145 
144 
144 
146 
146 
145 
145 
143 
144 
144 
143 
149 
Figure: Amino acid sequence comparison of the SODI protein in 15 different species. 
All SODI protein sequences were obtained from GenBank. The protein sequence comparison was performed using DNASTAR package software 
(DNASTAR Inc., Wisconsin). The amino acids representing the novel mutations reported in this article are boxed. Hyphens indicate amino acid 
deletions. 
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detected over 90% of all mutations, suggesting that few, if any, 
were missed in our screen. Therefore, 14.3% of our FALS families 
showed a defect in the SOD1 gene, confirming the relatively low 
prevalence of SOD 1 mutations found in previous studies.8-22 
We found three new mutations in exon 2 replacing Glu 21 by 
Gly, Leu 38 by Arg and Glu 49 by Lys. At the position 21, a 
Glu21Lys mutation was previously reported in one sporadic case of 
ALS.23The SOD1 protein of all compared species in the Figure 
contain the Glu 21, except chicken and nematodes, showing that this 
amino acid is highly conserved. Based on the bovine and yeast 
crystallographic SOD1 protein structure21 Glu 21 is part of a B 
strand. Thus the Glu21Gly mutation may destabilize the SOD1 
structure. As predicted for Leu38Val mutation,21 Leu38Arg would 
be expected to destabilize protein folding by altering a Greek Key. 
The bovine and yeast crystallographic SOD1 protein structure21 
show that Glu 49 is involved in dimer contact or Cu2+ binding. 
While the amino acid Glu 49 is not highly conserved between 
species, this substitution constitutes a significant amino acid change 
from a negatively charged (Glu) to a positively charged (Lys) amino 
acid. 
In exon 4 we found another novel mutation, Leu84Phe, and two 
previously published mutations Asp90Ala and Ilel 13Thr in six 
unrelated families. One of our families carrying an Asp90Ala 
mutation contains two affected patients and two normal individuals 
who are homozygotes and heterozygotes, respectively for the 
mutation (B. Moulard and Y. Boukaftane, in preparation). This 
finding supports a recessive inheritance mechanism for the 
Asp90Ala mutation.5-9 The Leu 84 amino acid is conserved in all 
known mammalian SOD1 genes (Figure), and it is a part of 
fourteen conserved amino acids region which would have an 
important role in SOD1 function. Surprisingly, the woman patient 
carrying the Leu84Phe mutation is homozygote. She died at the age 
of 43 years, 3 years after the onset of the disease. She has a 48-
year-old normal sister found also to be homozygous for the same 
mutation. 
We also found a deletion of three nucleotides 30 bp downstream 
of the exon-intron splice junction in intron 4. The consequence of 
this mutation is unknown. The patient and his parents have died 
and no cell line is available to test for splicing errors or other 
biological effects. However, the mutation is not seen in 600 control 
chromosomes. 
We found one kindred showing a missense mutation (CTA to 
CGA; Leu67Arg) in exon 3 which encodes the Zn-binding loop of 
the active site. This mutation replaces a predicted Leu at position 67 
by an Arg, introducing a voluminous amino acid with a positive 
charge, which constitutes a major structural change. The Zn2+ ion is 
known to be a potential neurotoxin.2426 Therefore, the alteration of 
SOD1 role in the binding of Zn2+ may affect its homeostasis 
leading to neurodegeneration. We have found two different 
mutations involving the Zn2+ binding site (Leu67Arg and 
Leu84Phe), in two unrelated FALS patients suggesting a possible 
role of Zn2+ ions in the development of ALS. 
This study increases the number of known mutations causing 
FALS to 55 involving 37 different codons. The fact that we have 
found 5 new missense mutations suggest there are other as yet 
undiscovered SOD1 mutations in FALS. This represents a 
surprisingly large number of gain of function mutations for such a 
small protein. 
Abbreviations 
ALS, Amyotrophic lateral sclerosis; FALS, familial ALS; 
SOD1, Cu/Zn superoxide dismutasel; SALS, sporadic ALS; SSCP, 
single strand conformational polymorphism. 
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